Meeting: EASL | DocGuide

Auto-generated: May 16 2012 01:42 PM GMT-8

Meeting: EASL

6

Stars

Source: DGNews | Posted 3 weeks ago

Interferon-Free Combination Regimen Shows Promise for the Treatment of Chronic HCV

Tags:

Read/Add Comments

2

Stars

Source: DGNews | Posted 3 weeks ago

Reduction of Tacrolimus Possible With Early Introduction of Everolimus After Liver Transplant

Tags:

Hepatitis

Read/Add Comments

82

Stars

Source: DGNews | Posted 3 weeks ago

Non-Interferon-Based Combination Therapy Offers High Response Rates for Hepatitis C Patients

Tags:

Read/Add Comments

5

Stars

Source: DGNews | Posted 3 weeks ago

Short-Term Aramchol Reduces Liver Fat Content Safely in Patients With NAFLD and NASH

Tags:

Read/Add Comments

6

Stars

Source: DGNews | Posted 3 weeks ago

Boceprevir Improves Rates of Sustained Virological Response in HCV/HIV Coinfected Patients

Tags:

Read/Add Comments

4

Stars

Source: DGNews | Posted 3 weeks ago

Novel Uridine Nucleotide Analogue Safe, Effective for Patients With HCV Receiving Pegylated Interferon/Ribavirin

Tags:

Read/Add Comments

4

Stars

Source: DGNews | Posted 3 weeks ago

Eltrombopag Increases Platelet Counts During HCV Treatment in Patients With Thrombocytopenia

Tags:

Read/Add Comments

4

Stars

Source: DGNews | Posted 3 weeks ago

Delaying Treatment in New Cases of Hepatitis C Infection Considered Unnecessary

Tags:

Read/Add Comments

4

Stars

Source: DGNews | Posted 3 weeks ago

Daclatasvir Plus PSI-7977 Provides Significant Response in Treatment of HCV Across Genotypes

Tags:

Read/Add Comments

3

Stars

Source: DGNews | Posted 3 weeks ago

Brivanib Improves Time-to-Progression in Patients With HCC, but Fails to Improve Overall Survival

Tags:

Read/Add Comments

Terms of Use | Privacy Policy

© All Content Copyright 1995 - 2012 Doctor's Guide Publishing Limited. All Rights Reserved.